NLINKN1 Chip+PRIME.StudySYNCRStentrode+$75M.SeriesDPRECNLayer 7+FDA.BrkthruPARAMArgo+$20M.SeriesBBLKRKNeuroport+200.ImplantsEMTIVMN8+$45M.SeriesBKRNLFlux+Non-invasiveNRBLEHalo+Consumer.BCINEURONeuroPace+RNS.SystemCOGNICognixion+ALS.TrialFUND.YTD2026$2.8B.SectorTRIALSActive50+.ClinTrialsIMPLNTSHumans~100.Intracrtnl
Terminal/Device DB/Forest 1 Ultrasound Scanner
ultrasoundnoneinvestigational

Forest 1 Ultrasound Scanner

Implant Type
ultrasound
Electrodes
0
Channels
0
FDA Status
none
Clinical Stage
UK safety trial at NHS (£6.5M ARIA-funded); 30 patients planned over 3.5 years
Status
investigational
About

Forest 1 is a research-grade ultrasound scanner smaller than a standard key fob, powered by Butterfly technology. When placed under the skull (or at a skull defect), it generates 3D maps of brain activity by detecting minute changes in blood flow with spatial resolution approximately 100x that of a typical MRI scan. Capable of both monitoring and modulating brain activity using ultrasound. ARIA has described it as 'the most advanced BCI in the world' for its unique ability to change activity across multiple brain regions simultaneously. The UK trial at Barking, Havering and Redbridge University Hospitals NHS Trust focuses on patients with craniectomies and those undergoing awake craniotomy.

Target Conditions
depressionanxietyepilepsyaddictionOCD
Milestones
2023-01Forest Neurotech nonprofit founded
2025-01£6.5M ARIA funding awarded for UK clinical trial
2025-03UK safety trial begins at NHS; 30 patients over 3.5 years
FDA Regulatory Pathway
No FDA Regulatory Status

This device does not have a current FDA designation. It may be a research tool, preclinical device, or consumer product not subject to FDA medical device regulation.

FDA Device Regulatory Guidance ↗
Other ultrasound Devices